

Toll-Free: (800) 266-7207  For Domestic | Intl: (404) 496-4049

  • Follow
  • Follow
  • Follow

Invest Now

  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Medical & Wellness Testing
  • Contact Us
  • News
  • Invest Now
  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Contact Us
  • Medical & Wellness Testing
  • News
  • Invest Now
Revolutionary Lifileucel Therapy: A New Era in Metastatic Melanoma Treatment

Revolutionary Lifileucel Therapy: A New Era in Metastatic Melanoma Treatment

Feb 18, 2024 | News | 0 comments

The recent FDA accelerated approval of lifileucel, known commercially as Amtagvi, marks a groundbreaking development in cancer therapy. This treatment is the first of its kind, a tumor-derived autologous T cell immunotherapy, specifically targeting patients with...
Identifying Early Warning Signs of COVID-19 Before Testing Positive

Identifying Early Warning Signs of COVID-19 Before Testing Positive

Feb 15, 2024 | News | 0 comments

As we navigate the chilly months of winter, we’re not just braving the cold but also a variety of respiratory illnesses, including COVID-19. Recent trends indicate a slight decrease in COVID-19 cases. For instance, hospital admissions have dropped from around...
Clear Health Pass™ Launches Revolutionary COVID Pet Test™ at VMX

Clear Health Pass™ Launches Revolutionary COVID Pet Test™ at VMX

Jan 17, 2023 | News | 0 comments

Protecting Our Furry Companions at the 40th Annual Veterinary Meeting & Expo (VMX) In 2023, we estimate that 76 million US pet owners will be infected with COVID-19, making the COVID Pet Test™ a vital tool in the fight against COVID-19”— John Cataldi, CEO of Clear...
New England Sees Rapid Rise in Immune-Evading COVID Variants BQ.1, BQ.1.1

New England Sees Rapid Rise in Immune-Evading COVID Variants BQ.1, BQ.1.1

Oct 25, 2022 | News | 0 comments

As various strains of Omicron have started popping up all over the US, New England has specifically seen a jump in BQ.1 and BQ.1.1: “New England has seen a rapid rise in the frequency of new immune-evading COVID-19 variants BQ.1 and BQ.1.1, with...
Omicron subvariants reflect a ‘viral evolution on steroids’

Omicron subvariants reflect a ‘viral evolution on steroids’

Oct 19, 2022 | News | 0 comments

Each day we move closer to the next wave of COVID, here’s the latest about the new variants and what to expect this coming season: “An omicron subvariant is once again demonstrating immune-dodging abilities, posing a threat to both vaccinated and...
The XBB family of Omicron has landed in the U.S. Here’s what it means for this fall’s COVID wave

The XBB family of Omicron has landed in the U.S. Here’s what it means for this fall’s COVID wave

Oct 18, 2022 | News | 0 comments

Here’s what we know about the latest omicron variant’s emergence in the United States: “XBB—a new, extremely immune-evasive Omicron variant surging in Singapore—hasn’t yet been detected in the U.S. But its child has. XBB.1 was first detected in the...
« Older Entries
Next Entries »

Recent Posts

  • Beyond the Pandemic: Confronting the Triple Menace of COVID-19, Flu, and RSV with Innovative Testing Solutions
  • Unseen Casualties of the Pandemic: How COVID-19 Led to Thousands of Missed Prostate Cancer Diagnoses in England
  • Unmasking Chronic Anxiety’s 95% Misdiagnosis Rate & Need for Precision Beyond Self-Recognition
  • Essential Knowledge about Prostate Cancer for Patients
  • Empowering Health Advocates: How Clear Health Pass is Revolutionizing Preventive Care with Ethical AI

Recent Comments

No comments to show.

ABOUT US

Clear Health Pass™ LLC acts as Authorized Representative of tribal, federally chartered corporations formed under Section 17 of the Indian Reorganization Act (IRA), U.S.C. Title 25.

(800) 266-7207
(404) 496-4049

 

 

OUR TESTS

  • Clear Health Pass MDHeartPro
  • Clear Health Pass MDDiabeticPro
  • Clear Health Pass MDGeneticPro Women’s Health
  • Clear Health Pass MDAllergyPro
  • Clear Health Pass MDDrugPro
  • Clear Health Pass NIPT

OUR PARTNERS

Under Disclaimers & Regulatory Disclosures

 

    • Use of Artificial Intelligence (AI)
    • CLIA Certification and Laboratory Accreditation
    • HIPAA Compliance and Data Security
    • FDA Compliance for Laboratory-Developed Tests 
    • Tribal Sovereignty and Compliance
    • Medical Disclaimer for Lab Testing & Result Interpretation
    • Quality Assurance Commitment
    • Third-Party Vendor Compliance
    • Safe Harbor Statement
    • Privacy Policy | Terms and Conditions

 

© 2022-2025 Clear Health Pass Holdings, LLC. All rights reserved. Clear Health Pass, DrugPro, GeneticPro, DiabeticPro, and HeartPro are trademarks of Clear Health Pass Holdings, LLC. Unauthorized use of these trademarks is strictly prohibited.